RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
Louis J. Sparvero(University of Pittsburgh), Michael T. Lotze(University of Pittsburgh)
Cited by 620
Related Papers
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Classification of current anticancer immunotherapies
|Oncotarget|2014|469
A guideline on the molecular ecosystem regulating ferroptosis
|Nature Cell Biology|2024|251
Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
|Frontiers in Immunology|2019|53